T suppressor activated lymphocytes (CD8 + /DR + ) inhibit megakaryocyte progenitor cell differentiation in a case of acquired amegakaryocytic thrombocytopenic purpura-Reference-Cited by-同舟云学术

T suppressor activated lymphocytes (CD8 + /DR + ) inhibit megakaryocyte progenitor cell differentiation in a case of acquired amegakaryocytic thrombocytopenic purpura

Published:1994-01 Issue:2 Volume:12 Page:205-213
ISSN:1066-5099
Container-title:STEM CELLS
language:en
Short-container-title:STEM CELLS

Author:

Benedetti Fabio¹,de Sabata Donata¹,Perona Giuseppe¹

Affiliation:

1. Department of Hematology, Verona University School of Medicine, Verona, Italy

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/stem.5530120209

Reference34 articles.

1. Acquired hypomegakaryocytic thrombocytopenic purpura. Occurrence in a patient with absent thrombopoietic stimulating factor

2. Thrombocytopenia with Decreased Megakaryocytes

3. Acquired amegakaryocytic thrombocytopenia: report of a case and review of literature;Manoharan A;Q J Med,1989

4. Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies

5. Amegakaryocytic thrombocytopenia

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia;Human Pathology Reports;2023-09

2. Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia;British Journal of Haematology;2022-05-10

3. Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia;Frontiers in Pharmacology;2022-01-27

4. Transient acquired amegakaryocytic thrombocytopenia associated with Pediatric Hodgkin Lymphoma: A case report;Pediatric Hematology Oncology Journal;2021-12

5. Acquired amegakaryocytic thrombocytopenia after durvalumab administration;Journal of Clinical and Experimental Hematopathology;2021